CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in

Laura Keil1, Céleste Chevalier1, Paulus Kirchhof1,2

  • 1Clinic for Cardiology, University Heart and Vascular Center Hamburg Eppendorf, 20246 Hamburg, Germany.

Insights

Non-ischemic cardiomyopathy (NICM) patients may benefit from implantable cardioverter-defibrillators (ICDs). Cardiovascular magnetic resonance imaging (CMR) aids in identifying NICM patients who will benefit most from ICD therapy for sudden cardiac death prevention.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Non-ischemic cardiomyopathy (NICM) is a significant cause of sudden cardiac death (SCD).
  • Current guidelines do not differentiate ICD implantation recommendations between NICM and ischemic cardiomyopathy (ICM).
  • Improved risk stratification is needed for NICM patients to identify those who benefit from ICD therapy.

Purpose of the Study:

  • To review the epidemiological aspects of SCD in NICM.
  • To evaluate the role of cardiovascular magnetic resonance imaging (CMR) in risk stratification for SCD in NICM.
  • To discuss resulting indications for implantable cardioverter-defibrillator (ICD) implantation in NICM.

Main Methods:

  • Review of existing epidemiological data on SCD in NICM.
  • Analysis of studies investigating CMR parameters (late gadolinium enhancement, T1 relaxation times, myocardial strain) for SCD risk stratification.
  • Evaluation of established predictors (genetic mutations, LVEF, LVEDD, TWA) alongside CMR findings.

Main Results:

  • CMR offers comprehensive analysis of cardiac function and myocardial tissue composition, potentially improving risk stratification.
  • Specific CMR parameters like LGE, T1 relaxation times, and myocardial strain are associated with SCD risk in NICM.
  • Integrating CMR with clinical and genetic predictors may refine patient selection for ICD therapy.

Conclusions:

  • Cardiovascular magnetic resonance imaging (CMR) shows promise in enhancing risk stratification for sudden cardiac death (SCD) in non-ischemic cardiomyopathy (NICM).
  • Further research integrating CMR with other predictors can optimize implantable cardioverter-defibrillator (ICD) implantation decisions in NICM patients.
  • Personalized risk assessment using advanced imaging is crucial for preventing SCD in NICM.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
129
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
144
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
102
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
162
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
91
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
74